Non Insulin Flashcards
Acarbose - Dosages
50 mg, 100 mg tablets
Acarbose - Pharmacology Class
α-Glucosidase inhibitor
Acarbose - Maximum Dose
300 mg/day in divided doses for patients over 60 kg, 150 mg/day for patients under 60 kg
Acarbose - Adverse Effects
Gastrointestinal issues (flatulence, abdominal pain, diarrhea), possible transient increase in hepatic enzymes, rarely hypoglycemia.
Acarbose - Administration Notes
Take with the first bite of each meal. Titrate dose slowly to minimize side effects. Not recommended for patients with severe renal impairment (serum creatinine >2 mg/dL). Use with caution in patients with liver disease or digestive issues.
Miglitol - Pharmacology Class
α-Glucosidase inhibitor
Metformin - Brand Names
Glucophage, APO-Metformin, Metforbax, Rehamet, Metfortex, Metfobet
Metformin - Dosages
500 mg, 750 mg, 1000 mg tablets, also available in extended release forms like Glucophage XR
Metformin - Pharmacology Class
Biguanide
Metformin - Maximum Dose
2550 mg per day
Metformin - Adverse Effects
Gastrointestinal issues (nausea, diarrhea, metallic taste), Vitamin B12 deficiency, rarely lactic acidosis, can cause weight loss or be weight neutral.
Metformin - Administration Notes
Take with food to minimize gastrointestinal side effects. Start with low doses and gradually increase. Avoid in patients with severe kidney disease (eGFR < 60 mL/min), liver disease, or alcohol abuse. Hold medication 48 hours before and after contrast imaging.
Gliclazide - Brand Names
Diamicron, Diabezid
Gliclazide - Dosages
30 mg, 60 mg, 80 mg tablets
Gliclazide - Pharmacology Class
Sulfonylurea
Gliclazide - Maximum Dose
320 mg
Gliclazide - Adverse Effects
Hypoglycemia, weight gain, GI issues. Hypersensitivity, potential for liver and blood problems.
Gliclazide - Administration Notes
Take with food. Use with caution in the elderly and those with kidney or liver disease.
Glibenclamide/Glyburide - Brand Names
Daonil, Glibutex
Glibenclamide/Glyburide - Dosages
1.25, 2.5 and 5mg
Glibenclamide/Glyburide - Pharmacology Class
Sulfonylurea
Glibenclamide/Glyburide - Maximum Dose
20 mg
Glibenclamide/Glyburide - Adverse Effects
Hypoglycemia, weight gain.
Glibenclamide/Glyburide - Administration Notes
Take with food. Use with caution in the elderly due to risk of hypoglycemia.
Glipizide - Pharmacology Class
Sulfonylurea
Glipizide - Maximum Dose
40 mg
Glipizide - Adverse Effects
Hypoglycemia, weight gain.
Glipizide - Administration Notes
Short-acting, may be preferred in elderly patients.
Glimepiride - Brand Name
Amaryl
Glimepiride - Dosages
1,2,3,4mg tabs
Glimepiride - Pharmacology Class
Sulfonylurea
Glimepiride - Maximum Dose
8 mg
Glimepiride - Adverse Effects
Hypoglycemia, weight gain.
Glimepiride - Administration Notes
Take with first meal of the day.
Repaglinide - Dosages
0.5 mg, 1 mg, 2 mg tablets
Repaglinide - Pharmacology Class
Glinide
Repaglinide - Maximum Dose
16 mg per day
Repaglinide - Adverse Effects
Hypoglycemia, weight gain.
Repaglinide - Administration Notes
Take with meals.
Nateglinide - Pharmacology Class
Glinide
Nateglinide - Adverse Effects
Hypoglycemia, weight gain.
Nateglinide - Administration Notes
Take before meals.
Pioglitazone - Dosages
15 mg, 30 mg, 45 mg tablets
Pioglitazone - Pharmacology Class
Thiazolidinedione (TZD)
Pioglitazone - Maximum Dose
45 mg
Pioglitazone - Adverse Effects
Fluid retention, edema, weight gain, potential risk for bladder cancer, liver failure, increased risk of fractures.
Pioglitazone - Administration Notes
Can be taken with or without food. Avoid in patients with heart failure. Monitor liver enzymes.
Rosiglitazone - Pharmacology Class
Thiazolidinedione (TZD)
Rosiglitazone - Adverse Effects
Increased risk of myocardial infarction (MI)
Canagliflozin - Pharmacology Class
SGLT2 inhibitor
Canagliflozin - Adverse Effects
Hypotension, increased risk of infection, increased risk of fractures, ketoacidosis, lower limb amputation.
Canagliflozin - Administration Notes
Not recommended for use in hospitalized patients due to risk of hypotension and ketoacidosis.
Empagliflozin - Brand Names
Jardiance, Glorypa, Synorypa
Empagliflozin - Dosages
10 mg, 25 mg tablets. Also available in combination with metformin.
Empagliflozin - Pharmacology Class
SGLT2 inhibitor
Empagliflozin - Adverse Effects
Hypotension, increased risk of infection, increased risk of fractures, ketoacidosis, lower limb amputation.
Empagliflozin - Administration Notes
Not recommended for use in hospitalized patients. Take at morning to not wet bed.
Dapagliflozin - Pharmacology Class
SGLT2 inhibitor
Dapagliflozin - Adverse Effects
Hypotension, increased risk of infection, increased risk of fractures, ketoacidosis, lower limb amputation.
Sitagliptin - Brand Name
Januvia, Sitavix, Ziptin
Sitagliptin - Dosages
25 mg, 50 mg tablets. Also available in combination with metformin (Januvex, Ziptin).
Sitagliptin - Pharmacology Class
DPP-4 inhibitor
Sitagliptin - Adverse Effects
Generally well tolerated, may cause hypoglycemia when used with other hypoglycemic agents.
Sitagliptin - Administration Notes
Can be taken once daily.
Saxagliptin - Pharmacology Class
DPP-4 inhibitor
Linagliptin - Brand Names
Linaglip, Melijent, Glorenta (combined with empagliflozin)
Linagliptin - Dosages
5 mg tablets. Available in combination with metformin (Melijent-M).
Linagliptin - Pharmacology Class
DPP-4 inhibitor
Linagliptin - Adverse Effects
Generally well tolerated, may cause hypoglycemia when used with other hypoglycemic agents.
Linagliptin - Administration Notes
Safe for use in patients with chronic kidney disease, no dose adjustment needed. Can be taken once daily.
Alogliptin - Pharmacology Class
DPP-4 inhibitor
Liraglutide - Brand Name
Victoza
Liraglutide - Dosages
Available as pre-filled pens. Initial dose is 0.6 mg daily, with gradual increase to 1.2 mg or 1.8 mg daily for diabetes management and 3 mg for weight management.
Liraglutide - Pharmacology Class
GLP-1 analog
Liraglutide - Adverse Effects
Gastrointestinal issues (nausea, vomiting), risk of pancreatitis and thyroid tumors, potential for kidney damage.
Liraglutide - Administration Notes
Inject subcutaneously once daily. Start at a low dose and gradually increase. Not recommended in pregnancy.
Exenatide - Pharmacology Class
GLP-1 analog
Exenatide - Adverse Effects
Gastrointestinal issues (nausea, vomiting), potential for kidney damage, risk of pancreatitis and hypersensitivity reactions.
Exenatide - Administration Notes
Administer subcutaneously 60 minutes before main meals. Not recommended for patients with severe kidney disease (CrCl<30 mL/min).
Albiglutide - Pharmacology Class
GLP-1 analog
Dulaglutide - Pharmacology Class
GLP-1 analog
Pramlintide - Brand Name
Symlin
Pramlintide - Pharmacology Class
Amylin analog
Pramlintide - Adverse Effects
Hypoglycemia when used with insulin, gastrointestinal issues.
Pramlintide - Administration Notes
Inject subcutaneously before meals. Reduce insulin dose when starting pramlintide. Avoid in patients with gastroparesis.
Colesevelam - Pharmacology Class
Bile acid sequestrant
Cholestyramine - Pharmacology Class
Bile acid sequestrant
Bromocriptine - Pharmacology Class
Dopamine-2 agonist